Work

Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations

Year: 2022

Type: article

Source: Nature Microbiology

DOI: 10.1038/s41564-022-01269-8

Authors: Gaëlle Frenois-Veyrat, Franck Gallardo, Olivier Gorgé, Elie Marcheteau, Olivier Ferraris, Artem Baidaliuk, Anne-Laure Favier, Cécile Enfroy, Xavier Holy, Jérémy Lourenco, Rhéa Khoury, Flora Nolent, Douglas W. Grosenbach, Dennis E. Hruby, Audrey Ferrier, Frédéric Iseni, Etienne Simon-Loriere, Jean-Nicolas Tournier

Institutions: Service de Santé des Armées, Institut Pasteur, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Siga Technologies (United States)

Language: English

Topic: Poxvirus research and outbreaks

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Agence Nationale de la Recherche, National Institute of Allergy and Infectious Diseases

Awards: Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa, Institut Convergences pour l’étude de l’Emergence des Pathologies au Travers des Individus et des populatiONs

OpenAlex ID: W4308464401

FWCI: 6.771

Cites: 25

Cited by: 94

Related to: 10